pharma · Glioblastoma, IDH-wildtype · SHPH
Shuttle Pharmaceuticals Holdings
Shuttle Pharmaceuticals Holdings trial registry — 1 ClinicalTrials.gov studies with program phase, status, and indication context.
Company details
- Status
- Public
- HQ
- Rockville, USA
- Founded
- 2012
- Employees
- 5
- Programs
- 1
- Drugs
- 1
- Patents
- 9
Shuttle Pharmaceuticals Holdings clinical trials
Registry index of 1 ClinicalTrials.gov studies linked to Shuttle Pharmaceuticals Holdings programs — each row shows trial ID, program name, phase, status, and indication.
Shuttle Pharmaceuticals Holdings trial registry — 1 ClinicalTrials.gov studies with program phase, status, and indication context.
Recent trial activity
Latest clinical program signals indexed for Shuttle Pharmaceuticals Holdings.
-
Ropidoxuridine — Phase 2
Clinical update -
Dual function molecules for histone deacetylase inhibition and ataxia telangiectasia mutated activation and methods of use thereof
Patent grant -
Dual function molecules for histone deacetylase inhibition and ataxia telangiectasia mutated activation and methods of use thereof
Patent grant -
Dual function molecules for histone deacetylase inhibition and ataxia telangiectasia mutated activation and methods of use thereof
Patent grant
Trial registry
-
CT.gov ↗